Marketing-authorisation holder · United States
Solaris Pharma Corp
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ESTRADIOL0.06% (1.25gm/activation) · Gel, metered | Estradiol | United States | Marketed | 2024 |
| TAZAROTENE0.05% | 0.1% · GEL | Tazarotene | United States | Marketed | 2022 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.